VIR-7831 for the Early Treatment of COVID-19 in Outpatients

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Covid19

In brief

This is a phase 2/3 study in which subjects with coronavirus disease 2019 (COVID-19) will receive VIR-7831 or placebo and will be assessed for safety, tolerability, efficacy, and pharmacokinetics.

Key facts

Study ID

NCT04545060

Run by

Vir Biotechnology, Inc.

People needed

1057

Starts

2020-08-27

Expected to finish

2021-09-02

Last updated by the study team

2022-11-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participant must be aged 18 years or older AND at high risk of progression of COVID-19 or ≥ 55 years old
• Participants must have a positive SARS-CoV-2 test result and oxygen saturation ≥94% on room air and have COVID-19 symptoms and be less than or equal to 5 days from onset of symptoms

You may not qualify if…

• Currently hospitalized or judged by the investigator as likely to require hospitalization in the next 24 hours
• Symptoms consistent with severe COVID-19
• Participants who, in the judgement of the investigator are likely to die in the next 7 days
• Severely immunocompromised participants

Where it is running

• Investigative Site — Cullman, Alabama, United States
• Investigative Site — Mesa, Arizona, United States
• Investigative Site — Tucson, Arizona, United States
• Investigative Site — Los Angeles, California, United States
• Investigative Site — Los Angeles, California, United States
• Investigative Site — Northridge, California, United States
• Investigative Site — Oxnard, California, United States
• Investigative Site — Rolling Hills Estates, California, United States
• Investigative Site — Sacramento, California, United States
• Investigative Site — Doral, Florida, United States
• Investigative Site — Gainesville, Florida, United States
• Investigative Site — Hialeah, Florida, United States
• Investigative Site — Miami, Florida, United States
• Investigative Site — Miami, Florida, United States
• Investigative Site — Miami, Florida, United States
• Investigative Site — Miami, Florida, United States
• Investigative Site — Miami, Florida, United States
• Investigative Site — Miramar, Florida, United States
• Investigative Site — North Miami, Florida, United States
• Investigative Site — Palmetto Bay, Florida, United States
• Investigative Site — Pembroke Pines, Florida, United States
• Investigative Site — Pompano Beach, Florida, United States
• Investigative Site — Tampa, Florida, United States
• Investigative Site — Tampa, Florida, United States
• Investigative Site — Anniston, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.